Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LivaNova PLC - Ordinary Shares (NQ:LIVN)

82.93 +1.88 (+2.32%)
Streaming Delayed Price Updated: 1:16 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LivaNova PLC - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
What Does LivaNova's Debt Look Like? ↗
Shares of LivaNova (NASDAQ:LIVN) fell by 3.55% in the past three months. Before having a look at the importance of debt, let us look at how much debt LivaNova has. LivaNova... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 ↗
Upgrades For Bank of Marin Bancorp (NASDAQ: 
Via Benzinga
News headline image
LivaNova to Host Conference Call for Second Quarter 2021 Results
From LivaNova PLC
Via Business Wire
News headline image
Recap: LivaNova Q1 Earnings ↗
Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share rose 6.06% year over year to $0.35, which beat... 
Via Benzinga
News headline image
LivaNova Receives FDA Approval for Clinical Study to Evaluate the aura6000 System to Treat Obstructive Sleep Apnea
From LivaNova PLC
Via Business Wire
News headline image
LivaNova Completes Initial Closing of Heart Valve Business to Gyrus Capital
From LivaNova PLC
Via Business Wire
News headline image
LivaNova to Present at the UBS Global Healthcare Virtual Conference
From LivaNova PLC
Via Business Wire
News headline image
LivaNova PLC (LIVN) Q1 2021 Earnings Call Transcript ↗
LIVN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
LivaNova Reports First Quarter 2021 Results
From LivaNova PLC
Via Business Wire
News headline image
LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression
From LivaNova PLC
Via Business Wire
News headline image
LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine
From LivaNova PLC
Via Business Wire
News headline image
LivaNova Achieves Clinical Milestone in Heart Failure Program
From LivaNova PLC
Via Business Wire
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Rosenblatt boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $800. NVIDIA shares fell 0.2% to $607.00 in pre-market trading. Keybanc boosted the price target... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.